Cargando…

Optimizing statin therapy for primary prevention of cardiovascular disease in type 2 diabetes mellitus patients: Exploring dose, class, and intensity

PURPOSE: To investigate the impact of statin use on primary prevention of cardiovascular disease (CVD) in patients with type 2 diabetes mellitus (T2DM) in a dose-, class-, and use intensity-dependent manner. METHODS: We used an inverse probability treatment-weighted Cox hazards model, with statin us...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Jung-Min, Chen, Wan-Ming, Shia, Ben-Chang, Wu, Szu-Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631324/ https://www.ncbi.nlm.nih.gov/pubmed/37933122 http://dx.doi.org/10.1177/14791641231214507

Ejemplares similares

Effects of Statin Dose, Class, and Use Intensity on All-Cause Mortality in Patients with Type 2 Diabetes Mellitus
por: Yu, Jung-Min, et al.
Publicado: (2023)

Optimal statin use for prevention of sepsis in type 2 diabetes mellitus
por: Sun, Mingyang, et al.
Publicado: (2023)

Statin for the Primary Prevention of Cardiovascular Disease in Patients with Diabetes Mellitus
por: Koo, Bo Kyung
Publicado: (2014)

Statins for primary cardiovascular prevention in the elderly
por: Pedro-Botet, Juan, et al.
Publicado: (2015)

Statin use and its association with decreased risk of esophageal squamous cell carcinoma in betel nut chewers
por: Lin, Chih‐Lang, et al.
Publicado: (2023)

Use of Aspirin and Statin as primary prevention for cardiovascular diseases
por: Alkhail, Bahaa Aba, et al.
Publicado: (2016)

Statins alone or polypill for primary prevention of cardiovascular diseases
por: Hasani-Ranjbar, Shirin, et al.
Publicado: (2016)

Statins for the primary prevention of cardiovascular disease: an overview of systematic reviews
por: Byrne, Paula, et al.
Publicado: (2019)

Moderate- to high-intensity statins for secondary prevention in patients with type 2 diabetes mellitus on dialysis after acute myocardial infarction
por: Li, Yan-Rong, et al.
Publicado: (2017)

Efficacy and Safety of Switching from Low-Dose Statin to High-Intensity Statin for Primary Prevention in Type 2 Diabetes: A Randomized Controlled Trial
por: Thongtang, Nuntakorn, et al.
Publicado: (2020)

Hoping rosuvastatin for primary prevention of cardiovascular events, are all statins similar and are we ready for statinizing the globe?
por: Kumar, Arun H. S.
Publicado: (2016)

Primary prevention with statins in cardiovascular diseases: A Saudi Arabian perspective
por: Mahmood, D., et al.
Publicado: (2015)

Systematic review of the predictors of statin adherence for the primary prevention of cardiovascular disease
por: Hope, Holly F., et al.
Publicado: (2019)

Role of Statin Therapy in Primary Prevention of Cardiovascular Disease in Elderly Patients
por: Strandberg, Timo E.
Publicado: (2019)

Statins for primary prevention of cardiovascular disease and the risk of acute kidney injury
por: Coste, Joël, et al.
Publicado: (2019)

Patterns of statin adherence in primary cardiovascular disease prevention during the pandemic
por: Malo, Sara, et al.
Publicado: (2022)

Compliance in Primary Prevention With Statins and Associations With Cardiovascular Risk and Death in a Low‐Risk Population With Type 2 Diabetes Mellitus
por: Malmborg, Morten, et al.
Publicado: (2021)

The use of statins in primary prevention
por: Rosian, Ingrid, et al.
Publicado: (2006)

Comparison of the efficacy and safety of intensive-dose and standard-dose statin treatment for stroke prevention: A meta-analysis
por: Wang, Juan, et al.
Publicado: (2016)

Variations in statin prescribing for primary cardiovascular disease prevention: cross-sectional analysis
por: Fleetcroft, Robert, et al.
Publicado: (2014)

Statins for primary cardiovascular disease prevention among people with HIV: emergent directions
por: Fitch, Kathleen V., et al.
Publicado: (2022)

Diabetes Mellitus and Cardiovascular Disease
por: Aganovic, Izet
Publicado: (2003)

Association of Primary Care Providers’ Beliefs of Statins for Primary Prevention and Statin Prescription
por: Clough, Jeffrey D., et al.
Publicado: (2019)

Aspirin for Prevention of Cardiovascular Disease
por: Mendy, Vincent L., et al.
Publicado: (2017)

Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta-analyses
por: Cai, Ting, et al.
Publicado: (2021)

The JUPITER study: statins for the primary prevention of cardiovascular events in patients with inflammatory rheumatic diseases?
por: Ward, Michael M
Publicado: (2009)

Formal comment on “Systematic review of the predictors of statin adherence for the primary prevention of cardiovascular disease”
por: Diamond, David M., et al.
Publicado: (2019)

New onset diabetes mellitus and cardiovascular events in Korean patients with acute myocardial infarction receiving high-intensity statins
por: Choi, Jah Yeon, et al.
Publicado: (2021)

Statins in primary prevention: is the enthusiasm justified?
por: Chopra, Arun K., et al.
Publicado: (2020)

Implications of lower risk thresholds for statin treatment in primary prevention: Analysis of CPRD and simulation modelling of annual cholesterol monitoring
por: McFadden, Emily, et al.
Publicado: (2015)

Sodium-glucose co-transporter-2 inhibitors in patients with type 2 diabetes mellitus without established cardiovascular disease: Do they have a role in primary prevention?
por: Kale, Shailaja, et al.
Publicado: (2021)

Statin intensity and risk for cardiovascular events after heart transplantation
por: Golbus, Jessica R., et al.
Publicado: (2020)

Aspirin and Simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes (ACCEPT-D): design of a randomized study of the efficacy of low-dose aspirin in the prevention of cardiovascular events in subjects with diabetes mellitus treated with statins
por: De Berardis, Giorgia, et al.
Publicado: (2007)

Survival effect of pre-RT PET-CT on cervical cancer: Image-guided intensity-modulated radiation therapy era
por: Su, Chih-Hsiung, et al.
Publicado: (2023)

Risk‐benefit analysis of use of statins for primary prevention of cardiovascular disease in subjects without diabetes
por: Chan, Juliana CN
Publicado: (2013)

Older adult preferences regarding benefits and harms of statin and aspirin therapy for cardiovascular primary prevention()
por: Wang, Frances M., et al.
Publicado: (2023)

Intensive statin versus low-dose statin + ezetimibe treatment for fibrous cap thickness of coronary vulnerable plaques
por: Meng, Pei-Na, et al.
Publicado: (2020)

To JUPITER and beyond: Statins, inflammation, and primary prevention
por: Rao, Ajay D, et al.
Publicado: (2010)

Statins for the Primary Prevention of Coronary Heart Disease
por: Li, Min, et al.
Publicado: (2019)

Effectiveness of an intervention designed to optimize statins use: a primary prevention randomized clinical trial
por: Fàbregas, Mireia, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_e9hlle407197hs2hekspfsop84